DS
NUVB icon

David Shaw’s Nuvation Bio NUVB Stock Holding History

David Shaw’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48M Buy
1,140,000
+747,014
+190% +$3.65M ﹤0.01% 2192
2026
Q1 		$1.69M Sell
392,986
-482,816
-55% -$2.69M ﹤0.01% 3044
2025
Q4 		$7.85M Buy
+875,802
New +$5.43M ﹤0.01% 1957
2025
Q2 		– Sell
-12,100
Closed -$21.3K – 4602
2025
Q1 		$21.3K Sell
12,100
-35,300
-74% -$80.4K ﹤0.01% 4103
2024
Q4 		$126K Sell
47,400
-63,827
-57% -$164K ﹤0.01% 4144
2024
Q3 		$255K Sell
111,227
-60,568
-35% -$185K ﹤0.01% 4057
2024
Q2 		$502K Sell
171,795
-689,145
-80% -$2.1M ﹤0.01% 3622
2024
Q1 		$3.13M Buy
860,940
+346,010
+67% +$664K ﹤0.01% 2266
2023
Q4 		$778K Buy
514,930
+446,959
+658% +$575K ﹤0.01% 3296
2023
Q3 		$91.1K Sell
67,971
-44,265
-39% -$73.7K ﹤0.01% 3864
2023
Q2 		$202K Buy
112,236
+32,535
+41% +$55.3K ﹤0.01% 3735
2023
Q1 		$132K Sell
79,701
-38,570
-33% -$78.2K ﹤0.01% 3958
2022
Q4 		$227K Sell
118,271
-100,554
-46% -$203K ﹤0.01% 4198
2022
Q3 		$490K Buy
218,825
+71,110
+48% +$203K ﹤0.01% 4056
2022
Q2 		$479K Buy
147,715
+114,937
+351% +$501K ﹤0.01% 4113
2022
Q1 		$172K Sell
32,778
-37,192
-53% -$209K ﹤0.01% 4906
2021
Q4 		$595K Sell
69,970
-95,521
-58% -$878K ﹤0.01% 4303
2021
Q3 		$1.65M Sell
165,491
-3,424
-2% -$31K ﹤0.01% 3198
2021
Q2 		$1.57M Buy
+168,915
New +$1.93M ﹤0.01% 3171
2021
Q1 		– Sell
-115,700
Closed -$1.35M – 4349
2020
Q4 		$1.35M Buy
+115,700
New +$1.2M ﹤0.01% 2823

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

David Shaw's NUVB Position: Q2 2026 in Review

David Shaw increased its Nuvation Bio (NUVB) stake by 190% in Q2 2026, buying an estimated $3.65M and bringing the position to 1,140,000 shares worth $6.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

David Shaw first reported a position in NUVB in Q4 2020 and has held it in 20 quarters since. The position peaked at $7.85M in Q4 2025. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • David Shaw held 1,140,000 shares of Nuvation Bio worth $6.48M as of Q2 2026.
  • David Shaw bought 747,014 Nuvation Bio shares in Q2 2026, an estimated $3.65M.
  • Nuvation Bio made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2192 holding.
  • David Shaw first reported a position in Nuvation Bio in Q4 2020 and has held it in 20 quarters since.
  • David Shaw's Nuvation Bio position peaked at $7.85M in Q4 2025.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.